Larvol Delta - Ashvattha-Therapeutics-Announces-Presentations-Highlighting-Mechanism-of-Action-for-Migaldendranib-in-Diabetic-Macular-Edema-and-Neovascular-AgeRelated-Macular-Degeneration

migaldendranib subcutaneous (D-4517.2 SC) - Ashvattha Therap

https://www.businesswire.com/news/home/20260428036042/en/Ashvattha-Therapeutics-Announces-Presentations-Highlighting-Mechanism-of-Action-for-Migaldendranib-in-Diabetic-Macular-Edema-and-Neovascular-Age-Related-Macular-Degeneration

Apr 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next